Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiple Mucosa-associated Lymphoid Tissue Lymphoma of the Trachea.
Minami D, Ando C, Sato K, Moriwaki K, Sugahara F, Nakasuka T, Iwamoto Y, Fujiwara K, Shibayama T, Yonei T, Sato T. Minami D, et al. Among authors: nakasuka t. Intern Med. 2017 Nov 1;56(21):2907-2911. doi: 10.2169/internalmedicine.8269-16. Epub 2017 Sep 25. Intern Med. 2017. PMID: 28943536 Free PMC article.
Rapidly Progressive Multiple Cavity Formation in Necrotizing Pneumonia Caused by Community-acquired Methicillin-resistant Staphylococcus aureus Positive for the Panton-Valentine Leucocidin Gene.
Takigawa Y, Fujiwara K, Saito T, Nakasuka T, Ozeki T, Okawa S, Takada K, Iwamoto Y, Kayatani H, Minami D, Sato K, Nagao M, Shibayama T. Takigawa Y, et al. Among authors: nakasuka t. Intern Med. 2019 Mar 1;58(5):685-691. doi: 10.2169/internalmedicine.1454-18. Epub 2018 Oct 17. Intern Med. 2019. PMID: 30333405 Free PMC article.
Patients' preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406.
Makimoto G, Hotta K, Oze I, Ninomiya K, Nakanishi M, Hara N, Kano H, Watanabe H, Hata Y, Nishii K, Nakasuka T, Itano J, Ninomiya T, Kubo T, Ohashi K, Ichihara E, Minami D, Sato A, Tabata M, Maeda Y, Kiura K. Makimoto G, et al. Among authors: nakasuka t. Acta Oncol. 2020 Mar;59(3):324-328. doi: 10.1080/0284186X.2019.1679880. Epub 2019 Oct 25. Acta Oncol. 2020. PMID: 31650873 No abstract available.
Randomized study comparing mannitol with furosemide for the prevention of cisplatin-induced renal toxicity in non-small cell lung cancer: The OLCSG1406 trial.
Makimoto G, Hotta K, Oze I, Ninomiya K, Nakanishi M, Hara N, Kano H, Watanabe H, Hata Y, Nishii K, Nakasuka T, Itano J, Ninomiya T, Kubo T, Ohashi K, Ichihara E, Minami D, Sato A, Tabata M, Maeda Y, Kiura K. Makimoto G, et al. Among authors: nakasuka t. Asia Pac J Clin Oncol. 2021 Feb;17(1):101-108. doi: 10.1111/ajco.13423. Epub 2020 Sep 3. Asia Pac J Clin Oncol. 2021. PMID: 32885583 Clinical Trial.
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers.
Watanabe H, Ichihara E, Kayatani H, Makimoto G, Ninomiya K, Nishii K, Higo H, Ando C, Okawa S, Nakasuka T, Kano H, Hara N, Hirabae A, Kato Y, Ninomiya T, Kubo T, Rai K, Ohashi K, Hotta K, Tabata M, Maeda Y, Kiura K. Watanabe H, et al. Among authors: nakasuka t. Cancer Sci. 2021 May;112(5):1853-1864. doi: 10.1111/cas.14801. Epub 2021 Mar 18. Cancer Sci. 2021. PMID: 33410241 Free PMC article.
SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1-, or EGFR-altered Non-small Cell Lung Cancer.
Kano H, Ichihara E, Watanabe H, Nishii K, Ando C, Nakasuka T, Ninomiya K, Kato Y, Kubo T, Rai K, Ohashi K, Hotta K, Tabata M, Maeda Y, Kiura K. Kano H, et al. Among authors: nakasuka t. Mol Cancer Ther. 2021 Sep;20(9):1653-1662. doi: 10.1158/1535-7163.MCT-20-0965. Epub 2021 Jun 22. Mol Cancer Ther. 2021. PMID: 34158345 Free article.
24 results